March 16, 2026 · Form 4 insider transaction
MAETZOLD DEREK J sold 126 shares of Castle Biosciences, Inc. at $26.68 per share, a transaction worth $3.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 3, 2025.